Conventional and novel stem cell based therapies for androgenic alopecia

    August 2017 in “ Stem cells and cloning
    Dodanim Talavera-Adame, Daniella Newman, Nathan Newman
    Image of study
    TLDR Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.
    The 2017 review "Conventional and novel stem cell based therapies for androgenic alopecia" discussed the potential of stem cell technologies and regenerative medicine for hair restoration in treating androgenic alopecia (AGA). The authors noted that hair follicle stem cells (HFSCs) and dermal papilla cells (DPCs) play a crucial role in hair growth, and that stem cells in culture can activate these cells to promote hair growth. The review also highlighted the efficacy of FDA-approved treatments like Minoxidil and Finasteride, despite their side effects. Additionally, the document discussed the potential of platelet-rich plasma (PRP) in treating AGA, citing several studies that demonstrated its efficacy in promoting hair regrowth. However, the authors emphasized that further research and clinical studies were needed to evaluate the efficacy of these novel therapeutic alternatives.
    View this study on →

    Cited in this study

    53 / NoResults


    9 / NoResults